申请人:THE WELLCOME FOUNDATION LIMITED
公开号:EP0542497A1
公开(公告)日:1993-05-19
Compounds of the formula (II):
or acid addition salts thereof, wherein R¹ is hydrogen, C₁₋₆ alkyl or C₁₋₄ alkyl substituted by halo or C₁₋₄ alkoxy, R² is C₁₋₄ alkyl or C₁₋₄ alkyl substituted b halo or C₁₋₄ alkoxy, R³ is C₁₋₄ alkyl
or C₁₋₄ alkyl substituted by halo or C₁₋₄ alkoxy or
forms a C₅₋₇ cycloalkyl or cycloalkenyl group and R⁴ is hydrogen or C₁₋₄ alkyl are described as useful medicaments in the treatment of cancer. Pharmaceutical compositions containing the compounds and their manufacture are also disclosed.
该公式(II)的化合物或其酸盐,其中R¹为氢、C₁₋₆烷基或通过卤素或C₁₋₄烷氧基取代的C₁₋₄烷基;R²为C₁₋₄烷基或通过卤素或C₁₋₄烷氧基取代的C₁₋₄烷基;R³为C₁₋₄烷基或通过卤素或C₁₋₄烷氧基取代的C₁₋₄烷基,或形成C₅₋₇环烷基或环烯基;R⁴为氢或C₁₋₄烷基。这些化合物被描述为治疗癌症的有用药物。还公开了含有这些化合物的药物组合物及其制备方法。